Glaxosmithkline Share News (GSK)

GRAPHIC-Miners' influence on FTSE wanes after tough year

LONDON, Jan 10 (Reuters) - Mining companies' influence on Britain's FTSE is fading after a tough year for the sector, although it still has a greater bearing on the UK blue chip index than on any other in Europe. UK-listed miners have operations from Kazakhstan to Chile and meet demand for

GSK receives US FDA approval for melanoma treatment Mekinist

GlaxoSmithKline (GSK) said its melanoma treatment Mekinist has been approved by the US Food and Drug Administration. Mekinist has been approved for use in combination with Tafinlar for the treatment of unresectable or metastatic melanoma with BRAF V600E or V600K mutations. The US regulatory gave

GSK melanoma drug combination wins accelerated U.S. approval

LONDON, Jan 9 (Reuters) - A combination treatment from GlaxoSmithKline for melanoma, the deadliest form of skin cancer, has won accelerated approval from U.S. regulators. The green light for the combined use of Tafinlar, also known as dabrafenib, and Mekinist, or trametinib, from the Food a

UPDATE 1-AstraZeneca raises bet on cancer immunotherapy with Immunocore deal

* MedImmune unit in drug development deal with UK biotech * Immunocore gets $20 mln upfront per programme * May get further $300 mln per programme, plus royalties By Ben Hirschler LONDON, Jan 8 (Reuters) - AstraZeneca has raised its bet on new treatments that harness the b

UPDATE 2-J&J, Pharmacyclics leukemia drug improves survival in study

(Adds analyst comment, background, updates share moves) By Bill Berkrot Jan 7 (Reuters) - An independent committee recommended a late stage trial of a cancer drug developed by Pharmacyclics Inc and Johnson & Johnson be stopped early as it became clear it helped patients with chronic l

DIRECTOR DEALINGS: Glaxo Divisional Chairman Allocated ADSs

Cable & Wireless Comms incoming Chief acquires 4.3m shares

Cable & Wireless Communications on Friday announced that soon-to-be Chief Executive Officer Phil Bentley had purchased 4.3m shares in the international telecoms operator. Bentley, the former Managing Director of British Gas, bought the shares the previous day at 56.912p each for a total spend of £

DIRECTOR DEALINGS: Glaxo Non-Executives Acquire Shares

GlaxoSmithKline Sells Lucozade And Ribena Brands To Suntory

China to introduce healthcare corruption "blacklist" in 2014

SHANGHAI, Dec 27 (Reuters) - China will introduce a blacklist of drugmakers and medical device manufacturers found to have paid bribes as it extends a crackdown on graft in the healthcare sector. Healthcare departments will compile lists of offending manufacturers, agents and individuals, w

London close: Stocks surge to two-and-a-half-week high after Fed taper

- FTSE 100 at highest since December 2nd after Fed taper - Fed scales back stimulus, gives guidance on rates - Carnival jumps late on after FY results - Pharmaceutical and life insurance stocks rise techMARK 2,735.02 +1.40% FTSE 100 6,584.70 +1.43% FTSE 250 15,589.95 +1.45% UK stocks surged to a t

FTSE 100 movers: Carnival buoyed by Q4 results, drugmakers higher

Cruise operator Carnival surged into the top spot on the FTSE 100 risers list on Thursday after reporting a smaller-than-expected decline in net revenue yields in the fourth quarter. Net revenue yields in constant dollars fell by 2.1 per cent year-on-year, better than the company's guidance given in

Broker tips: GlaxoSmithKline, Serco, Britvic

Jefferies has maintained its 'hold' rating for GlaxoSmithKline (GSK) after Denmark approved the sale of a generic copy of its top-selling inhaled lung drug, Advair. "Sandoz/Vectura's EU branded generic of Advair/Seretide was anticipated, though the timing was uncertain. Confirmation of its approval

London midday: Markets jump one per cent after Fed taper

- Fed tapers monthly asset purchases by 10bn dollars - Markets rise, Wall Street hits record high - Annual growth of UK retail sales misses estimates techMARK 2,732.70 +1.31% FTSE 100 6,556.63 +0.99% FTSE 250 15,576.80 +1.37% UK markets had held on to their gains by Thursday lunchtime as investors

Broker snap: Generics threat tightens breathing room at Glaxo, says Jefferies

Jefferies has maintained its 'hold' rating for GlaxoSmithKline (GSK) after Denmark approved the sale of a generic copy of its top-selling inhaled lung drug, Advair. It was announced on Thursday that Novartis' Sandoz and Vectura have been given the green light by Danish authorities for the V315 AirF